Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (830)

71

Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates

enthalten in: Science advances | 2023

von Meng, Q. | Tai, W. | Tian, M. | +15

72

Improving COVID-19 Disease Severity Surveillance Measures : Statewide Implementation Experience

enthalten in: Annals of internal medicine | 2023

von Doron, S. | Monach, P. | Brown, C. | +1

73

The Japanese Guide affected the prescription of steroids for COVID-19 inpatients during the COVID-19 epidemic in Japan

enthalten in: Scientific reports | 2023

von Higuchi, T. | Shin, J. | Takada, D. | +3

74

Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone : a potential fatality reducing agent

enthalten in: Journal of translational medicine | 2023

von Liu, D. | Saeed, A. | Majaz, S. | +3

75

Autopsy Findings of Severe COVID-19 Pneumonia Combined with Pulmonary Aspergillosis, Pneumothorax, and Pulmonary Thromboembolisms

enthalten in: The American journal of case reports | 2023

von Kanaji, N. | Kimura, N. | Kondo, A. | +6

76

Computational studies suggest compounds restoring function of p53 cancer mutants can bind SARS-CoV-2 spike protein

enthalten in: Journal of biomolecular structure & dynamics | 2023

von Das, T. | Mukhopadhyay, C.

77

Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi

enthalten in: BMC infectious diseases | 2023

von Wadhwa, B. | Malhotra, V. | Kerai, S. | +15

78

The post-COVID stress syndrome: from the three-stage stress response of Hans Selye to COVID-19

enthalten in: Inflammopharmacology | 2023

von Szabo, S.

79

Evaluation of the Drug-Drug Interaction Potential of Ensitrelvir Fumaric Acid with Cytochrome P450 3A Substrates in Healthy Japanese Adults

enthalten in: Clinical drug investigation | 2023

von Shimizu, R. | Sonoyama, T. | Fukuhara, T. | +4

80

Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone

enthalten in: Infectious diseases (London, England) | 2023

von Leding, C. | Bodilsen, J. | Brieghel, C. | +27